N. Terrigino

Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy

P. Choyke, M. Merino, S. Harmon, 2020, medRxiv.

Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer

G. Bubley, S. Trostel, S. Balk, 2019, bioRxiv.

Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response

P. Choyke, M. Merino, S. Harmon, 2020, Clinical Cancer Research.

A case report of multiple primary prostate tumors with differential drug sensitivity

P. Choyke, M. Merino, S. Harmon, 2020, Nature Communications.